XBiotech (XBIT) Profit After Tax (2014 - 2026)
XBiotech (XBIT) posted quarterly Profit After Tax of -$26.9 million for Q4 2025, down 155.92% year-over-year from $48.1 million in Q4 2024, and down 347.6% quarter-over-quarter from -$6.0 million in Q3 2025.
XBiotech (XBIT) Profit After Tax (2014 - 2026) Analysis & Trends
XBiotech's Profit After Tax history runs 12 years deep, the most recent figure standing at -$26.9 million for Q4 2025.
- In Q4 2025, Profit After Tax fell 155.92% year-over-year to -$26.9 million; the TTM figure through Dec 2025 stood at -$45.5 million (down 18.19% YoY), while the FY2025 annual figure was -$45.5 million, down 18.19% from the prior year.
- Profit After Tax for Q4 2025 stood at -$26.9 million, down from -$6.0 million in the prior quarter.
- The five-year high for Profit After Tax was -$1.8 million in Q2 2025, with the low at -$26.9 million in Q4 2025.
- The 5-year median for Profit After Tax is -$6.2 million (2021), against an average of -$7.9 million.
- The sharpest annual moves came in 2021 and 2025: Profit After Tax tumbled 18242.86% in 2021, then surged 86.5% in 2025.
- XBiotech's Profit After Tax stood at -$6.5 million in 2021, then soared by 50.47% to -$3.2 million in 2022, then tumbled by 44.71% to -$4.6 million in 2023, then slumped by 126.71% to -$10.5 million in 2024, then tumbled by 155.92% to -$26.9 million in 2025.
- Business Quant data shows XBIT's Profit After Tax at -$26.9 million in Q4 2025, -$6.0 million in Q3 2025, and -$1.8 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 472.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 164.49 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -16.62 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 81.49 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -355.03 Mn |
| 10 | XBiotech | 68.90 Mn | 68.90 Mn | - | -6.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.73 Mn |
| Dec 31, 2025 | -26.89 Mn |
| Sep 30, 2025 | -6.01 Mn |
| Jun 30, 2025 | -1.76 Mn |
| Mar 31, 2025 | -10.88 Mn |
| Dec 31, 2024 | -10.51 Mn |
| Sep 30, 2024 | -5.02 Mn |
| Jun 30, 2024 | -13.01 Mn |
| Mar 31, 2024 | -10.00 Mn |
| Dec 31, 2023 | -4.64 Mn |
| Sep 30, 2023 | -7.36 Mn |
| Jun 30, 2023 | -8.74 Mn |
| Mar 31, 2023 | -3.82 Mn |
| Dec 31, 2022 | -3.20 Mn |
| Sep 30, 2022 | -12.66 Mn |
| Jun 30, 2022 | -11.64 Mn |
| Mar 31, 2022 | -5.40 Mn |
| Dec 31, 2021 | -6.47 Mn |
| Sep 30, 2021 | -3.26 Mn |
| Jun 30, 2021 | -5.12 Mn |